News

Lantern Pharma's Upcoming Q3 2025 Results Webcast Details

Lantern Pharma's Upcoming Q3 2025 Results Webcast Details

Lantern Pharma to Host Third Quarter 2025 Results Webcast

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering company in artificial intelligence used for cancer therapy development, will announce its third quarter 2025 operating and financial results via a webcast. This event is scheduled for Thursday, November 13 at 9:00 a.m. Eastern Time / 6:00 a.m. Pacific Time.

Details of the Webcast

The upcoming webcast promises to provide a comprehensive overview of the company's performance during the third quarter, specifically focusing on the period ended September 30, 2025. Key discussions will cover operational results, financial insights, and guidance on future milestones and developments.

Management Team Engagement

During the call, Panna Sharma, the President and CEO of Lantern Pharma, will be at the forefront, joined by other critical members of the management team. Their insights will reflect on the company's strategic direction and share details about their AI platform, RADR®. This platform embodies their commitment to enhancing the drug development process for cancer therapies.

How to Participate

To participate in the webcast, interested parties can register through the provided Zoom link in advance. This ensures that stakeholders gain real-time insights into the company's performance as well as future strategies.

About Lantern Pharma

Lantern Pharma leverages its RADR® platform, integrating cutting-edge AI and machine learning technologies into the discovery, development, and commercialization of innovative cancer therapies. The focus remains on optimizing the development timelines while enhancing therapeutic opportunities and patient outcomes.

Visit Our Website for More Information

For details about the company and its initiatives, please visit their official website. Regular updates and information can be found there to keep investors informed about Lantern Pharma's progress.

Frequently Asked Questions

When is the Lantern Pharma Q3 2025 results webcast?

The webcast is scheduled for November 13, 2025, at 9:00 a.m. Eastern Time.

Who will lead the webcast discussion?

Panna Sharma, President and CEO of Lantern Pharma, will lead the discussion during the webcast.

What will be discussed during the webcast?

The call will cover operating and financial results, along with guidance on upcoming milestones and challenges.

How can I participate in the webcast?

Participants can register in advance using the Zoom registration link provided for the event.

What is the core focus of Lantern Pharma?

Lantern Pharma focuses on utilizing AI to speed up cancer therapies' discovery and development while improving patient outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NPKI Faces Legal Scrutiny After Financial Setback

Updated Category News Views 63

Stockholders Left Scrambling You ever have one of those days where everything is cruising along, then bam—you hit what feels like a pothole the size of Texas? Well, that's NPK International (NYSE: NPKI) right now. Their recent revenue cut sent shareholders spiraling, and now there's a legal storm brewing, led by Levi & Korsinsky. Weather Woes Lead to Lower Earnings So,...

Continue Reading
BCD Travel Faces Class Action Probe After Data Breach

Updated Category News Views 81

Class Action Stirred by BCD Travel Data Breach Here's the scoop, folks: Edelson Lechtzin LLP, a heavyweight in the world of class action law firms, is sniffing around BCD Travel Services B.V. over a juicy data breach that left about 700,000 traveler records flapping in the wind. Grab your coffee—this one's got all the trimmings of a modern-day digital fiasco. The Breach...

Continue Reading
Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Updated Category News Views 88

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Continue Reading
Legacy of Professor Raymond Yukna: A Laser Pioneer

Updated Category News Views 66

End of an Era in Periodontology For those of us who have a stake in the world of dental technology, today hangs heavy. We talk about innovators, pioneers, and game-changers all the time, but Dr. Raymond A. Yukna wasn't just another name on that list - he was the list. The guy practically wrote the book on modern periodontal therapy. With his passing, we're not just saying...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 56

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Principle Health Expands Missouri, Illinois Imaging Services

Updated Category News Views 84

Diving Deeper into Principle's Strategic Move Principle Health Systems just took a sizable step by acquiring assets from a mobile diagnostic imaging company around St. Louis. Now they're elbow-deep into Missouri and Illinois, beefing up their ability to deliver bedside X-rays, ultrasounds, and EKGs straight to the patients in long-term care facilities. It ain't just about...

Continue Reading
Investigation of Maplebear Sale to DoorDash Sparks Debate

Updated Category News Views 174

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Continue Reading
Ensign Lawsuit Deadline Looms: Investors, Wake Up!

Updated Category News Views 77

A Storm Brewing in Healthcare Here's what will make any half-savvy investor's pulse quicken: The Ensign Group, Inc. (NasdaqGS: ENSG) is in hot legal water, and there's a hefty class action floating around with some serious allegations. ClaimsFiler's got the word out, marking December 7, 2026, as the cut-off date for investors wanting to be part of this securities class...

Continue Reading
SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Updated Category News Views 25

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

Continue Reading
Springbrook's AI Push: Transforming Local Governance

Updated Category News Views 116

Revolutionizing Government Tech with AI Springbrook Software is positioning itself as a frontrunner in modernizing government tech, unveiling a suite of AI-driven innovations under its Cirrus ERP platform. During their recent conference, Activate 2026, held in Orlando, the commitment to transforming how local governments operate was clear. With new tools like AI Invoicing...

Continue Reading

Top 5 Most Recently Viewed Articles

ThreeD Capital Inc. Expands Its Private Placement Financing Efforts

Updated Category News Views 102

ThreeD Capital Inc. Expands Its Private Placement Financing Efforts ThreeD Capital Inc., a dynamic venture capital firm based in Canada, has recently announced a significant enhancement to its private placement financing. Aiming to attract extensive investments within the junior resources and disruptive technologies sectors, the Company is poised for an exciting new...

Continue Reading
Elon Musk's Funding Cuts Impacting Education Research Profoundly

Updated Category News Views 466

Significant Funding Cuts to Education Research The U.S. Department of Education's research division, known as the Institute of Education Sciences, faces a staggering loss of nearly $900 million in funding. This decision stems from a review led by a department under Elon Musk, which has abruptly terminated approximately 169 contracts that were pivotal in supporting...

Continue Reading
Market Reaction: ASML Holding NV and Chip Stocks Decline

Updated Category News Views 270

Chip stocks faced a brutal wake-up call back in 2024 when ASML Holding NV dropped a bomb with its cautious outlook. Investors weren't just twitching; they were reeling. The announcement didn't just stir the pot—it blew up the kitchen, leading to losses that exceeded $420 billion across an index of US-traded chipmakers and major Asian semiconductor firms. ASML’s Grim...

Continue Reading
AMD Unveils Groundbreaking Graphics and Processor Innovations

Updated Category News Views 405

AMD Launches Revolutionary Radeon Graphics Cards and Ryzen Processors At COMPUTEX 2025, AMD showcased its new game-changing technologies, highlighting the Radeon RX 9060 XT and the Ryzen Threadripper PRO 9000 Series processors. These innovations are set to redefine both gaming and professional computing, targeting demanding workloads with exceptional performance. Next-Gen...

Continue Reading
Experience the Magic of Halloween in Ireland's Treasures

Updated Category News Views 180

Experience the Enchantment of Halloween in Ireland As the fall season approaches, the excitement for Halloween grows, and there's no better place to embrace this magical time than in Ireland. Known as the original home of Halloween, Ireland presents a unique opportunity to experience a rich tapestry of celebrations steeped in history and myth. With origins rooted in the...

Continue Reading